It’s not at all clear what a tariff would mean for Novo, which manufactures its medicines in facilities all over the world, ...
Denmark is the latest in a series of countries that President-elect Donald Trump has threatened with tariffs — joining a list ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...
Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Novo Nordisk shares fell 30% in the fourth quarter on disappointing clinical trial data, concerns about its experimental ...
Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...
Novo Nordisk's prospects look attractive despite a recent clinical setback. AstraZeneca would be performing well if not for ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback